Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Intralinks Holdings, Inc.
NEW YORK, Sept. 11, 2013 /PRNewswire/ -- Intralinks® Holdings, Inc. (NYSE: IL), a leading, global SaaS provider of inter-enterprise content management and collaboration solutions, and IRB Services™ (Institutional Review Board Services), a leading, global provider of research ethics review and related services for the clinical research and behavioral science industries, striving for excellence in human research participant protection, today announced that the IRB Services team has selected Intralinks VIA™ to support all of its secure beyond the firewall collaboration needs.
One of the largest institutional review boards in North America, IRB Services independently reviews, monitors and provides oversight of biomedical and behavioral research involving humans, working with many of the largest pharmaceutical and clinical research organizations (CROs), including many of the world's most respected and recognized brands. IRB Services will be the first central institutional review board to license Intralinks VIA to facilitate the transfer of sensitive documents that are required during the approval process that every large pharmaceutical company (sponsor) or CRO must go through. This approval process happens during all phases of research in a clinical trial's lifecycle and is essential to the commencement of a new or ongoing project.
"More and more clients have been requesting secure portals to help with the exchange of regulatory documents required during the clinical trial process," said Simon A. Corman, director, Business Operations at IRB Services. "Our team is excited to use Intralinks VIA to facilitate this process. We looked at many collaborative solutions, but only Intralinks provides the security and ease-of-use we need. Further, as the first central IRB to implement the Intralinks VIA solution, we will be able to leverage the existing widespread Intralinks user base to maximize efficiencies and further solidify our position as a market leader. Utilizing a collaboration platform that we can trust with sensitive information around clinical trials on a global scale will help bolster our services in the eyes of our clients and accelerate the clinical trial process, which is always a plus."
Intralinks provides breakthrough collaboration solutions that give demanding professionals the freedom to work confidently beyond traditional boundaries. Intralinks VIA is an elegantly simple enterprise collaboration solution that makes it easy for anyone to sync, share and UNshare™ files, work efficiently on group projects, and manage content wherever it goes – all with robust security and strong control capabilities. Used by over 99 percent of the global Fortune 1000, Intralinks' solutions go beyond just file sharing to ensure that productive work gets done, while protecting that work wherever it goes.
"IRB Services works with virtually all of the big pharmaceutical companies, CROs and research sites, and adding Intralinks VIA will only make IRB Services more competitive," said Douglas Gordon, senior vice president, product marketing at Intralinks. "As a market leader in ethics review services, we are proud IRB Services selected Intralinks to support its collaboration needs."
About IRB Services
Founded in 1993, IRB Services is an independent organization dedicated to protecting the rights and safety of human research subjects. As one of the largest central institutional review boards in North America, IRB Services is an experienced, service-driven organization dedicated to excellence in human research participant protection and committed to providing industry leading efficient customer-oriented services. IRB Services provides ethical review of clinical trials and behavioral science research and operates ethics committees in Boca Raton, Florida; Montréal, Québec; and Toronto, Ontario; which review a wide range of both industry and publicly funded human subject research across multiple disciplines, including Food and Drug Administration, US Department of Health and Human Services, and Health Canada regulated research. IRB Services has received full accreditation from the Association for the Accreditation of Human Research Protection Programs. For more information please visit http://www.irbservices.com.
Intralinks Holdings, Inc. (NYSE: IL) is a leading, global technology provider of inter-enterprise content management and collaboration solutions. Through innovative Software-as-a-Service solutions, Intralinks solutions are designed to enable the exchange, control and management of information between organizations securely and compliantly when working through the firewall. More than 2.7 million professionals, including professionals at 99% of the Fortune 1000 companies, depend on Intralinks' experience. With a track record of enabling high-stakes transactions and business collaborations valued at more than $23.5 trillion, Intralinks is a trusted provider of easy-to-use, enterprise strength, cloud-based collaboration solutions. For more information, visit www.Intralinks.com.
Forward Looking Statements
The forward-looking statements contained in this press release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are express or implied statements that are not based on historical information and include, among other things, statements concerning Intralinks' plans, intentions, expectations, projections, hopes, beliefs, objectives, goals and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control and could cause actual results to differ materially from those contemplated in these forward-looking statements. Accordingly, there can be no assurance that the results expressed, projected or implied by any forward-looking statements will be achieved, and readers are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements in this press release speak only as of the date hereof. As such, Intralinks undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For a detailed list of the factors and risks that could affect Intralinks' financial results, please refer to Intralinks' public filings with the Securities and Exchange Commission from time to time, including its Annual Report on Form 10-K for the year-ended December 31, 2012 and subsequent quarterly reports.
Trademarks and Copyright
"Intralinks" and Intralinks' stylized logo are the registered trademarks of Intralinks, Inc. This press release may also refer to trade names and trademarks of other organizations without reference to their status as registered trademarks. © 2013 Intralinks, Inc. All rights reserved.
©2012 PR Newswire. All Rights Reserved.